COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case seriesShort communication Published on 2022-09-012022-10-05 Journal: Journal of the neurological sciences [Category] 변종, 유전자 메커니즘, [키워드] adverse event Affect age AstraZeneca Bilateral case sery characterized clinical clinical feature cohort of patient collected COVID-19 COVID-19 vaccination COVID-19 vaccines cranial dose feature first vaccination fluctuations Guillain-barrè syndrome hospital Inflammatory Italy Liguria Mild symptom Moderna multicenter negatively affected occur Oxford-AstraZeneca Patient patients Peripheral nervous system Pfizer-BioNTech post-COVID-19 vaccination predominant Prognosis Region Result SARS-CoV-2 second dose syndrome Treatment vaccination vaccine dose variant [DOI] 10.1016/j.jns.2022.120330 [Article Type] Short communication
Anti-SARS-CoV-2 vaccination does not influence anticoagulation levels in stable long-term warfarin treatmentArticle Published on 2022-09-012022-11-16 Journal: Blood transfusion = Trasfusione del sangue [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome Administered administration age anti-SARS-CoV-2 vaccination anticoagulation bleeding coronavirus COVID COVID-19 vaccination criteria criterion Diseases dose Effect Evidence first vaccination Follow-up high risk INR material medication No bleeding no difference OAT outbreak pandemic Patient Population Ratio reported required SARS-CoV-2 second dose Sex stability subject the patient therapy thrombotic complication Treatment vaccination Vaccine vaccine administration were recorded [DOI] 10.2450/2022.0271-21 PMC 바로가기
Humoral and Cellular Immune Responses to Vector, Mix-and-Match, or mRNA Vaccines against SARS-CoV-2 and the Relationship between the Two Immune ResponsesArticle Published on 2022-08-312022-11-15 Journal: Microbiology Spectrum [Category] SARS, 진단, 치료기술, [키워드] Abbott acute respiratory syndrome Affect affected affecting age age and sex analyzed anti-SARS-CoV-2 antibody Antibody detection BAU binding antibody unit BNT162b2 cellular Cellular immune response cellular immune responses ChAdOx1 nCoV-19 coronavirus correlation Cutoff demonstrated determine Effect Elecsy evaluated Factor female first vaccination Genscript group humoral humoral immune responses immune immune response immune responses interferon gamma investigated male mix-and-match vaccine mRNA mRNA vaccine mRNA-1273 neutralizing antibody predict Qiagen QuantiFERON RBD regimen regimens relationship response robust Roche SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 neutralization second vaccination Sex subject T cell response T cell responses the receptor-binding domain vaccination Vaccine vaccine group vector vector vaccine venous blood was collected were used [DOI] 10.1128/spectrum.02495-21 PMC 바로가기
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 백신 BNT162b2 또는 mRNA-1273 투여 후 면역저하 환자의 항체 반응: 무작위 대조 시험Randomized Controlled Trial Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, 진단, [키워드] 1:1 95% confidence interval acute respiratory syndrome addition Antibody Response BNT162b2 Cohort Controlled coronavirus coronavirus 2 Cutoff Efficacy Elecsy first vaccination had no HIV Human immunodeficiency virus immune response immunoassay Immunocompromised patient Immunocompromised patients infections intention-to-treat analysis kidney lung Moderna mRNA-1273 Open-label organ Organ transplant Patient Pfizer-BioNTech platform Platform trial PLWH Prevent primary endpoint proportion Protein Randomized randomized clinical trial Randomized controlled trial Receptor binding domain recipient respiratory response SARS-CoV-2 SARS-CoV-2 spike second vaccination solid organ transplant the antibody response Transplant Vaccine was measured [DOI] 10.1093/cid/ciac169 PMC 바로가기 [Article Type] Randomized Controlled Trial
Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workersSARS-CoV-2 S 펩타이드에 대한 T 세포 반응을 평가하기 위한 상용화된 키트. 의료 종사자를 대상으로 한 파일럿 연구Article Published on 2022-08-122022-09-11 Journal: Medicina clínica [Category] SARS, 진단, 치료기술, [키워드] antibody Antibody test antibody tests Automation BNT162b2-mRNA-COVID-19-vaccine Cell mediated immunity CLIA complement Concordance correlation COVID-19 detect dose ELISA English Ensayos de liberación Interferon-gamma feasibility first vaccination group groups HCW Health care worker IFNγ immune response Immunosuppressed individual Infection Inmunidad Mediada por Células interferon Interferon-gamma-release-assays mRNA natural infection number of sample number of samples peptides pilot study positive Quantitative ranged risk S-protein SARS-CoV-2 SARS-CoV-2 N SARS-CoV-2 S SARS-CoV-2 vaccines Sensitivity and specificity Spanish susceptible T-cell Response T-cell responses vaccine dose Vacuna BNT162b2-mRNA-COVID-19. [DOI] 10.1016/j.medcli.2021.09.013 PMC 바로가기 [Article Type] Article
Measurements of Anti-SARS-CoV-2 Antibody Levels after Vaccination Using a SH-SAW BiosensorSH-SAW 바이오센서를 이용한 예방접종 후 Anti-SARS-CoV-2 항체 수치 측정Article Published on 2022-08-042022-09-12 Journal: Biosensors [Category] SARS, 진단, [키워드] adenovirus vaccine adverse effect Anti-SARS-CoV-2 S antibody antibody concentration biosensor Blood Blood clots BNT chronic disease coated with Concentration COVID-19 pandemic cut-off diagnostic system fatigue first vaccination Health help in vitro increasingly induce Level Local measurement Moderna MONITOR mRNA vaccines myocarditis Pain pandemic Patient prevalence of COVID-19 Prevent Protein reduce SARS-CoV-2 SARS-CoV-2 spike protein second vaccination SH-SAW biosensor vaccination Vaccinations Vaccine was determined [DOI] 10.3390/bios12080599 PMC 바로가기 [Article Type] Article
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis류마티스 관절염 환자에서 SARS-CoV-2 백신 접종에서 BNT162b2 mRNA를 포함한 부스터의 역할Article Published on 2022-08-012022-09-12 Journal: Immunologic research [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] addition age Analysis analyzed anti-IL6 antibody BAU BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine booster booster vaccination Booster vaccine Case report csDMARDs Disease activity Effect evaluated evidenced first vaccination Flow cytometry analysis HCW HCWs Health care worker IgG IgG level indicated jak inhibitors Level lymphocyte subpopulation mRNA BNT162b2 Necrosis Patient patients positive predictor RBD IgG Regression Rheumatoid rheumatoid arthritis role RTX SARS CoV-2 SARS-CoV-2 vaccination Seroconversion serum antibody spike therapy TNF treated Treatment vaccination Vaccination SARS-CoV-2 was determined [DOI] 10.1007/s12026-022-09283-y PMC 바로가기 [Article Type] Article
Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study심각한 동반이환이 있는 고령 인구의 혈청학적 COVID-19 백신 반응 및 내구성과 관련된 특성: 덴마크 전국 ENFORCE 연구Article Published on 2022-08-012022-09-12 Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 진단, [키워드] adjusted age antibody baseline ChAdOx1 Characteristics COVID-19 COVID-19 vaccination COVID-19 vaccine declined decrease defined enrolled first vaccination functional hyporesponsiveness identify IgG Immunity increasing age individual interquartile lack Level Male sex median age mRNA vaccine mRNA-1273 number of comorbidity older population outcomes parallel group participant Responder response risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination serological Sex spike vaccination Vaccine vaccine dose vaccine response vaccine-induced antibodies vaccine-induced antibody waned were measured [DOI] 10.1016/j.cmi.2022.03.003 PMC 바로가기 [Article Type] Article
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers의료 종사자의 BNT162b2 추가 접종 후 면역원성 평가Article Published on 2022-07-262022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] BNT162b2 booster booster vaccination Contact contact with exposure to first vaccination followed by HCW healthcare worker Healthcare workers humoral Humoral response IgA IgA antibodies IgA antibody IgA level IgA levels IgG IgG level IgG levels immune response Immunity immunogenicity implementation increase in Infection Measures new virus pandemic patients Registered restored SARS-COV-2 infection significantly statistically subject the antibody vaccination Vaccine variants virus [DOI] 10.1038/s41598-022-16759-2 PMC 바로가기 [Article Type] Article
Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model영국 2차 유행 중 의료 종사자의 SARS-CoV-2 감염 부담과 백신의 영향: 전향적 다기관 코호트 연구(SIREN) 및 수학적 모델Multicenter Study Published on 2022-07-202022-09-11 Journal: The BMJ [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval adjusted odds ratio assistant booster booster vaccination booster vaccinations burden Chain Reaction clinical Cohort cohort study conducted Coverage COVID-19 pandemic determine Effect emergency department England enrolled Evidence evidence of exposure to Factor first vaccination FIVE greater health organisation healthcare Healthcare provision healthcare worker Healthcare workers help highlight hospital Households incidence indicated infected with SARS-CoV-2 Infection Infection prevention ISRCTN likelihood lockdown Logistic regression maintain mathematical mathematical model multicentre multivariable analysis National National Health Service no evidence of Omicron variant outcome pandemic participant Patient peaked polymerase chain polymerase chain reaction predict Prevention and control proportion prospective cohort study PROTECT responsible risk factor Risk factors SARS-COV-2 infection second wave secondary care SIREN Support susceptible the SARS-CoV-2 time Transmission dynamics vaccination Vaccination Status Vaccine Vaccines variants was obtained was used with infection [DOI] 10.1136/bmj-2022-070379 PMC 바로가기 [Article Type] Multicenter Study